Q2 2024 PetVivo Holdings Inc Earnings Call
Positive response from veterinary doctors, specifically in the small animal side.
I was at the U S that show last week in New York City, and I would have to say over 70% of the bets what I when they saw the springs shirt made comments about the product and that really sets us up nicely.
With having the mwr Rep say, but of course, these smaller and more reps.
Speaker 1: with having the MWI reps able to call on these small animal reps.
Our back from sorry.
Speaker 1: So the positive results that we got from Ethos that we presented about, not us, but the Ethos clinician presented ACBS about six weeks ago, really adds to help solidify the argument or the proposition that was made in the Tammy Grubb article, which was a peer review article on spring as being a first use product.
So the positive results that we got from <unk> that we presented about not us, but the ethos Clinton attrition presented a CBS about six weeks ago really adds to help solidify the.
Argument or the proposition that was made in the Etame Grub article, which was a peer review article on spring has been a first use product.
Speaker 1: The other part of that article was that spring would be an excellent alternative, a very good alternative.
The other part of that article was that spring is would be an excellent alternative for very good alternatives.
Speaker 1: to dogs that have a negative reaction to NSAIDs, which is the gold standard therapy. So about 5% of the dogs out of the 83 million dogs would have an issue taking NSAIDs.
Two.
Dogs that have a reaction negative reaction to headsets, which is the stat gold standard therapy, so about 5% of the dogs out of the $83 million in dogs would have an issue taken nsaids and the argument there was that spring would be a great alternative and with this status.
Speaker 1: And the argument there was that spring would be a great alternative. And with this data, we're able to really start marketing to the small animal vets. We are also gathering a lot of key opinion leaders in the marketplace in the small animal side.
We're able to really start.
Marketing to the small <unk>. We are also gathering a lot of key opinion leaders in the marketplace in the small animal side.
You are talking about spring at the various conferences and that was one of the goals we wanted to get to.
Speaker 1: are talking about spring at the various conferences and that was one of the goals we wanted to get to a couple years ago when we first went on NASDAQ we talked about
A couple of years ago. When we first went on NASDAQ we talked about the importance of podium presentations at all of these conferences that are coming up because it's the kols or key opinion leaders that talk about spring and now we're starting to get scientific data support.
Speaker 1: the importance of podium presentations at all these conferences that are coming up because it's the KOL, the key opinion leaders that talk about spring. And now we're starting to get scientific data to support the first use thesis because the first use thesis
First use these fields. The first use thesis gives a much better opportunity for veterinary doctors to adopt versus using the product on the <unk>.
Speaker 1: a much better opportunity for veterinary doctors to adopt, versus using the product on the worst case animals, which they call last years, or disasters.
Worst case animals, which they call last year.
Or disasters to try that.
Speaker 1: save the dog from being put down. And we're seeing very good results from that aspect, but we want the vets to think about it beyond last use and go to first.
Save the dog from being put down and we're seeing very good results from that aspect, we want them to think about it beyond last use and go to first use.
Okay.
Speaker 1: We are very excited about the American Association of Equine Practitioners Conference in San Diego this year. It's the starts November 30th and ends December 2nd. It's the largest
We are very excited about the American Association of equine practitioners conference in San Diego This year.
The.
Starts November 30 and ends December 2nd.
It's the largest.
Speaker 1: equine conference of the year and we have two of our veterinary doctors that we'll be presenting and so there'll be uh Dr. Tom Yavor will be giving a presentation
<unk> client conference of the year.
And we have two of our veterinary doctors that we'll be presenting and.
So there'll be a Dr <unk> will be giving a presentation.
Speaker 1: on which is entitled Modern Wild West Navigating the New Classes of Joint Therapy.
Which is entitled modern Wild West navigating the new classes of joined therapies.
Speaker 1: And Dr. Jill Manning will be presenting on achievements in interarticular therapies, experiences, and novel collagen.
And Dr. Joel Manning will be presenting on achievements and into articulate therapies experiences and novel collagen.
Speaker 1: hydrogel microparticles. It's CEHM. A lot of words there.
Hi, Joe.
Michael part across C.
A lot of words there.
So.
Speaker 1: So we're excited with the type of information and presentation. So we expect that to be a very good conference in adding a lot more equine practitioners and clinics to our network.
We're excited with the type of information and presentation. So we expect that to be a very good conference.
Adding a lot more.
Decline practitioners and clinics to our network.
We also plan to have some of our clinical data from the <unk>.
Speaker 1: We also plan to have some of our clinical data from Ethos and Inovex at the various trade shows coming up in the small animal side. In January , we have BMX, which is the Veterinary Medical Expo. It's the largest conference for small animals in the United States, and that's in Orlando.
And <unk> at the various trade shows coming up.
In the small animal side in January we have BMX, which is the veterinary medical Expo.
The largest conference for small animals in United States and Thats in Orlando.
Speaker 1: And then followed by that is the WBC, Western Veterinary Conference in February in Las Vegas. That's the largest show in the West Coast pretty much. And then DOS.
And then followed by that is the WBC Western Veterinary conference in February.
In Las Vegas, that's the largest show in the West coast pretty much and then pass.
Which is also in February so these three major shows where small animal with the data.
We talked about the white papers for cats and dogs.
That will be published here will help provide a lot of ammunition for the sales team to call on the small animal veterinary doctors and.
Speaker 1: It makes me feel really good from the New York show that I would say over 70% of the vets have heard about spring and they're happy to, when they're called upon by the sales reps now wanna learn more about it.
Basically I feel really good from the New York show that I would say over 70% of the bats have heard about spring and they're happy to when they are called upon by the sales reps now.
Learn more about it.
Speaker 1: Finally, we're gonna be really pushing the social media awareness for the small animals. 55% of pet ownership is right now with the millennials and Gen Z. And they're the ones that are spending whatever it takes to provide a improvement in quality of life and better healthcare outcomes for the animals.
Finally, we're going to be really pushing the social media awareness for the smaller animals.
55% of pet ownership is right now with the millennials.
And Gen Z and they are the ones that are spending whatever it takes to provide a improvement in quality of life and better healthcare outcomes for the animals.
Speaker 1: So, we feel with the distribution or that the clinics that we have in the majority of the states and the number of clinics, we can take this approach now to drive social media. And also, we're able to
So we feel with the distribution or that the clinics that we have and the majority of the states and the number of clinics. We can take this approach now to drive social media.
And also we're able to can.
Speaker 1: convey the message to the pet owners that we're able to provide a much more efficient cost structure. And in the long run, it helps the pet owner reduce the cost of working with osteoarthritis and other lameness issues. And that over time, they're gonna have better medical outcomes and savings because they don't have the side effects of the various other products.
Conveyed the message to the pet owners that we're able to provide.
A much more efficient cost structure and in the long run it helps the pet owner.
<unk> the cost of working with osteoarthritis and other lameness issues and that over time, they're going to have better medical outcomes and savings because they don't have the side effects of the various other products.
Speaker 1: And with that operator, I would like to open it up to Q&A.
And with that operator, I would like to open it up to Q&A.
Speaker 2: With pleasure, yes. To ask a question, if you are on a phone, please press star 9 to raise or lower your hand and press star 6 to mute or unmute when you are selected.
With pleasure yes.
You ask a question if you're on a phone.
Please press star nine to raise or lower your hand and place six to mute on mute when you ask.
<unk>.
If youre on a desktop <unk> raise your hand, and I will chair.
Speaker 2: With that, any questions, please? I will also insert the instructions for muting and unmuting into the chat.
With that any questions. Please I'll also insert the instructions for music and meeting the needs of the chat.
Any questions.
Yeah.
Speaker 2: Again, we are in the Q&A now for the PIT VIVO earnings call. If you're on a desktop, simply raise your hand and I will unmute you. You will then be allowed to fire away. If on a phone, please press star nine to raise.
Again, we are in the Q&A now for the Pic vivo earnings call as you all know desktop simply raise your hand and I'll on mute you. You will then be allowed to favor wage if on a phone.
Please press star nine to raise that long ago and.
Speaker 2: and install 6 to toggle mute or unmute.
And then star six to toggle mute or on mute.
Thank you.
Speaker 1: You know, since I don't see any questions, this is John , I'll give a quick overview of the general market for the pet industry. So recent numbers, we've seen, you know, the pet industry are being put in to many of the stocks that were COVID stocks. Oh, sorry, I think I do see a question. So I'll answer the question before I talk about the industry.
Since I don't see any questions. So this is John My I'll give a quick overview of the general market for pet for the pet industry.
So recent numbers we've seen.
The HUD industry are being put in too many of the stocks that add where COVID-19 stocks I'm, sorry, I think I do see a question. So I'll answer the question before I talk about the industry.
Yes.
On a scale from an anonymous attained in what's happening with the drastic stock drop.
Speaker 2: From an anonymous attendee, what's happening with the drastic stock drop?
Speaker 1: So that was part of my overview of the industry. So the pet industry has become out of favor because if you look at the macro numbers, pre-COVID, there was 68% home ownership or pet ownership. And then after the COVID, it was 71%. Recently, we saw the number of pet ownership dropped to 66%. And if you look at the microcap stock,
So that was part of my overview of the industry. So the patent industry has become out of favor because if you look at the macro numbers pre COVID-19 there were 68% homeownership for pet ownership and then after the Covid It was 71% Risa.
And we saw the number of pet ownership dropped to 66% and if you look at the Microcap stocks, specifically in the pet industry.
Speaker 1: specifically in the pet industry, under 100 million. In the last 60 days, we have seen an average of 35% decline within the veterinary, within the pet space. Now, the difference here is
Under $100 million in the last 60 days, we have seen an average of 35% decline within the veterinary within the pet space now the different series.
Speaker 1: Other companies that are dropping are pretty much like Me Too companies. So if you look at Blue Diamond, the reduction of food sales went way down.
Other companies that are dropping off pretty much like me to company. So if you look at Blue Diamond the reduction of food sales when weighed down and well I shouldn't say I shouldn't pick up there, but is the premium products have come down to mainstream products. So they are buying the prenup. So everybody is cutting cost cutting.
Speaker 1: And well, I shouldn't say, I shouldn't pick on that, but it's the premium products have come down to mainstream products. So they're buying the Purina. And so everybody's cutting expenditures down within the pet industry. So we're kind of lumped in. And if you look at the stocks that were part of the COVID stocks, they took 80, 90% hits in their stock. If you're looking at the pet industry.
Expenditures down within the pattern. This resort kind of lumped in and if you look at the stocks that were part of the Covid stocks. They took 80, 90% hips and their stocks. If you look at the pet industry Youre seeing in the small caps could be much the same type of action now.
Speaker 1: You're seeing in the small caps pretty much the same type of action now, obviously.
Obviously, I think where.
Speaker 1: put into the long segment within there because our product.
Put into the wrong segment within there because our product is quite disruptive and it's actually saving the consumer money as well as providing better medical outcomes and lot of these studies are supporting that argument as well as Dr. Tammy Grumps peer review article talking about how.
Speaker 1: is quite disruptive, and it's actually saving the consumer money, as well as providing better medical outcomes. And a lot of these studies are supporting that argument, as well as Dr. Tammy Grubb's peer review article talking about how our products should be looked at by veterinary doctors as first use and as alternatives to NSAIDs. Which is, both of those segments are very large and a very large market potential for us. Thank you.
Our products should be looked at by veterinary doctors is first used and as alternatives to handsets, which is both of those segments are very large and a very large market potential for us.
Thank you inevitably swung snore feature usage charge.
Speaker 2: your phone with those prompts in the chat or.
Johan with the strike in the charge or.
Raise your hand Guy Gamestop.
Speaker 2: If there's nothing else, could we please confirm the information and the contact details where attendees can require or get more information?
Theres nothing else could we please confirm.
The information and contact details their eye candy skin require or get more information.
And operator, I see one more one more <unk>.
Item in the chat I think it's directed to John So you don't guarantee a near term rebound is the RV assets. So as you know.
Speaker 1: So, as you know, when you get near year-end and you have this type of drop within the market, because it has been a horrible microcap market, the dispersion between the S&P 500 and the Russell 3000 hasn't been this wide in probably.
When you get near year end and you have this type of drop with in the market.
Because it has been a horrible microcap market the dispersion between the S&P 500, and the Russell 3000 Hasnt.
It Hasnt been this widened probably 40 years.
Speaker 1: in terms of total return for each one of the respective indexes. So you tend to get tax loss selling. Now, every year, you're seeing tax loss selling occur, especially.
In terms of total return for each one of the respective index. So you tend to get tax loss selling now every year youre seeing Tac plus settlement occur, especially.
Speaker 1: at the institutional level. So it's likely we're experiencing some tax loss selling and one would expect that to end relatively soon. And given the fact we're getting all this clinical data and we've got all these major shows coming up, the AAP at the end of this month of November and then early January and February , we got three major small animal shows.
At the institutional level. So it it's likely we're experiencing some tax loss selling and one would expect.
Expect that to end relatively soon and given the fact, we're getting all this clinical data and we got all these major.
Shows coming up D E. P. At the end of this month of November and then early January and February we got three major small animal shows. We believe those are really good catalysts as well as the white papers being published so so there is a lot of enthusiasm among.
Speaker 1: we believe those are really good catalysts as well as the white papers being published. So there is a lot of enthusiasm among.
Speaker 1: our management team, as well as the salespeople, because we're seeing this data that now we can go after small animals. So just to give an example, the equine space has about 8 million horses in the United States.
Our management team as well as the salespeople because we're seeing this data that now we can go after small animals. So just to give an example, the equine space antibody.
And horses in the United States.
Speaker 1: In terms of dogs, there's about 83 million dogs and keep in mind if you look at the alternative use
In terms of dogs, Theres about 83 million dogs and keep in mind. If you look at the alternative use IV the dogs that can't taken subs and spring being an alternative use 5% of that $83 million is a very good candidate for one from an economic standpoint to from.
Speaker 1: I mean, the dogs that can't take NSAIDs in spring being an alternative use, 5% of that 83 million is a very good candidate for one, from an economic standpoint, two, from an efficacy standpoint, and then also we have 60 million cats.
<unk>.
Efficacy standpoint, and then also we have $60 million cash so the cab safety study will be out in white paper form.
Speaker 1: So the cat safety study will be out in white paper form here relatively soon. So with all that, we really expand the potential market.
Here relatively soon so with all that we really expand the potential market size.
Speaker 1: Operator, so if there's no more questions, I think we can conclude the call.
Operator, so theres no more questions I think we can conclude the call.
Speaker 2: Correct, yes. Perhaps just leave, I did post a communication channel, the website and an email address where they can contact you, but if you wanna reiterate another contact as you close off, that'll be great. Thank you so much.
Correct, yes, perhaps just any that I did.
Post communication channel the website and an email address or they can contact you, but if you want to reiterate another contract as you close out that'll be great. Thank you so much.
Speaker 1: Yes, thank you. Yeah, we have the info one at petfeeble.com always too if you need to send a question email wise. And a lot of the shareholders actually know me pretty well and they call me direct. So feel free to call if you have any follow up questions. And thank you for attending the call. This concludes the formal Q&A.
Yes. Thank you.
Yeah, we have the.
And for one that pet vivo dotcom always too if you need the Senate question email wise and lot of the shareholders extra week, Nuomi pretty well and they call me direct so feel free to call or if you have any follow up questions and thank you for attending the call. This concludes the.
Formal Q&A presentation.